Which scenario would trigger quarantining a compounded preparation due to quality concerns?

• A. Quarantine the affected preparation
• B. Release for use
• C. Continue testing without quarantine
• D. Repackage and ship immediately

Answer: (A)

When there are quality concerns about a compounded preparation, you place it on hold and quarantine it. This means isolating the affected lot from available inventory and restricting its handling until QA reviews the issue and determines the proper disposition. The goal is to prevent potentially defective or unsafe material from reaching patients while the root cause is investigated. Releasing it for use would bypass the hold and risk patient safety. Continuing testing without quarantine could allow a flawed lot to proceed without first addressing the quality issue. Repackaging and shipping immediately would skip the quarantine step and could spread material that hasn’t met all quality standards. After investigation, the product can be cleared, returned to supplier, reprocessed, or discarded according to policy.